🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

59 results for “Vera” Clear

  1. CYP2C19 genotyping

    Vera Therapeutics

    Myocardial Infarction

    approved gene therapy completed

    1 trial

  2. Dexmedetomidine

    First Tracks Biotherapeutics

    Overall Survival

    approved small molecule completed

    1 trial

  3. Experimental: Hyperslim

    Vera Therapeutics

    Venous Thromboembolism (VTE)

    approved other active

    1 trial

  4. Resveratrol

    First Tracks Biotherapeutics

    Pancreatitis, Acute

    approved small molecule active

    1 trial

  5. VERAPAMIL , NEBIVOLOL , PROPAFENONE , BISOPROLOL , AMIODARONE , FLECAINIDE , SOTALOL , DILTIAZEM

    Pari Pharma GmbH

    Asymptomatic Patients with frequent PVCs and normal LVEF

    approved small molecule active

    1 trial

  6. Beverage powder fortified with micronutrients and Bacopa monnieri extract

    COGNITION THERAPEUTICS INC

    Cognition

    other completed

    1 trial

  7. Citrus Limonoid Beverage

    United Therapeutics Europe Ltd

    Hypercholesterolemia

    other completed

    1 trial

  8. Immune-enhancing nutritional beverage

    United Therapeutics Europe Ltd

    Mitigation of Immune Function Decrements in Response to Stress

    other completed

    1 trial

  9. Nitazoxanide Tablets

    Vera Therapeutics

    COVID-19

    small molecule completed

    1 trial

  10. Resveratrol, curcumin

    Atrium Therapeutics

    Effect of Resveratrol and Curcumin on Inflammation

    other completed

    1 trial

  11. Solifenacin Succinate

    China SXT Pharmaceuticals

    Overactive Bladder

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources